Keeping Track: Cardio-Renal Drugs At Heart Of US FDA’s March Approval Binge

 
• By Bridget Silverman
  
Keeping Track Feature image
The US FDA approved seven new molecular entities and novel biologics in March. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers